<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200214046492N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-04-01</date_registration>
      <primary_sponsor>Yasouj University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of mixed ethanolic extract (Black seed and Dill seeds) on pain and post partum hemorrage</public_title>
      <acronym>PPH</acronym>
      <scientific_title>Evaluation of the effect of mixed ethanolic extract (Black seed and Dill seeds) on some parameters of postpartum maternal physical health compared with mefnamic acid</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46129</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Use 2 ethanol herbal in one capsule, Randomization description: The study units will be divided into groups A and B on the basis of random allocation by computer random generation. The appearance of the drug and placebo will be quite similar. The participants and the researcher are completely unaware of the drugs, but the pharmacist is aware (double-blinded), Blinding description: The patient and nurse do not know kind of medicine. All patient was taken the same shape medicine.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Postpartum hemorrhage and pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group A: The black seeds and dill seeds are each washed separately and after drying in the shade, the plant will be milled, and extracted with 70% ethanol for 48 hours by maceration technique. The hydroalcoholic solution is then separated by filter paper from the plant particles and the remaining ethanol is collected by a rotary machine. The residue of the extract is kept at 37 ° C for evaporation. Finally, the dried extract is stored at 20 ° C for testing in the clinical laboratory. The selective dose of the dried extract in the combined capsule in the present study was 500 mg of black seed and 400 mg of dill daily. It should be noted that the relevant dose has been selected after studying the previous articles, evaluating human safety and the opinion of the consultant professor. Intervention 2: Intervention group B: Mefenamic acid will be completely similar in appearance to group A and will be administered in the same manner. Mefenamic acid will be administered 250 mg every six hours during the first three days after delivery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information about main outcomes of the study

When:
Six months after publishing the results

To whom:
Researchers in universities and scientific and research centers

Conditions:
In order to improve the control of postpartum hemorrhage and pain, and subsequent researches, and with the permission of the authors

Where to obtain:
Department of Obstetrics and Gynecology of Yasuj university of medical sciences

How to obtain:
Sending the request in writing or by email to the authors

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elaheh Foroutanifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Sajad Hospital, Saheli Str</address>
        <city>Yasuj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>75919-94799</zip>
        <telephone>+98 74 3322 0116</telephone>
        <email>vestal2475@yahoo.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Bazarganipoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Sajad Hospital, Saheli Str</address>
        <city>Yasuj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>75919-94799</zip>
        <telephone>+98 74 3322 0162</telephone>
        <email>vestal2475@yahoo.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gestation age 38-42 week
Singletone pregnancy
NVD
Mother age 15-44
iranian
spontaneous placental remove
no previous surgery
no spinal or opium
HB&gt;8
no ROM &gt;12
no opium addiction
no sensetive to herbal
no percipitate labor or prolonge labor
BMI 18/5-29/5
Fetal weight 2500-4000
no disease in mother
no operative vaginal delivery
no 3,4 degree laceration
no use warfarin,banzodiazepin,ASA,Alcohol,heparin</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>44 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>no breast feeding
no cooprative patient
use another herbal
no sensetive to herbal
severe dissease in mother and neonate</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O72.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other immediate postpartum hemorrhage</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group A: The black seeds and dill seeds are each washed separately and after drying in the shade, the plant will be milled, and extracted with 70% ethanol for 48 hours by maceration technique. The hydroalcoholic solution is then separated by filter paper from the plant particles and the remaining ethanol is collected by a rotary machine. The residue of the extract is kept at 37 ° C for evaporation. Finally, the dried extract is stored at 20 ° C for testing in the clinical laboratory. The selective dose of the dried extract in the combined capsule in the present study was 500 mg of black seed and 400 mg of dill daily. It should be noted that the relevant dose has been selected after studying the previous articles, evaluating human safety and the opinion of the consultant professor.</i_keyword>
      <i_keyword>Intervention group B: Mefenamic acid will be completely similar in appearance to group A and will be administered in the same manner. Mefenamic acid will be administered 250 mg every six hours during the first three days after delivery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Postpartum hemorrhage. Timepoint: Before study then first hour till 6hrs then till 3days. Method of measurement: Iranian GYN and OB protocol.</prim_outcome>
      <prim_outcome>Pain. Timepoint: Before study then first hour till 6hrs then till 3days. Method of measurement: Visual Analogue Scale Score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Breast feeding. Timepoint: Three days in the time of intervention then 2 weeks later. Method of measurement: Urination and defication of neonate.</sec_outcome>
      <sec_outcome>Liver function. Timepoint: After intervention. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Complete Blood Count. Timepoint: After intervention. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Renal function. Timepoint: After intervention. Method of measurement: Blood test.</sec_outcome>
      <sec_outcome>Sodium, Potassium. Timepoint: After intervention. Method of measurement: Blood test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yasouj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-13</approval_date>
        <contact_name>Ethics committee of Yasuj University of Medical Sciences</contact_name>
        <contact_address>Faculty of medicine, Medical campus, Next to Imam Sajjad Hospital, Shahid Dr. Ghorban Ali Jalil Ave Yasuj Kohgilouyeh-va-Boyrahmad Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
